Spots Global Cancer Trial Database for isolated limb perfusion
Every month we try and update this database with for isolated limb perfusion cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma | NCT00002492 | Sarcoma | cisplatin doxorubicin hyd... isolated limb p... conventional su... brachytherapy radiation thera... | 18 Years - 120 Years | University of Miami | |
| A Randomized Controlled Study Comparing Priming Solution Containing Crystalloid or Packed Red Blood Cells in Patients Treated With Isolated Limb Perfusion. | NCT03073304 | Melanoma Sarcoma | Crystalloid bas... Erythrocyte bas... | 18 Years - | Vastra Gotaland Region | |
| A Randomized Controlled Study Comparing Priming Solution Containing Crystalloid or Packed Red Blood Cells in Patients Treated With Isolated Limb Perfusion. | NCT03073304 | Melanoma Sarcoma | Crystalloid bas... Erythrocyte bas... | 18 Years - | Vastra Gotaland Region | |
| Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg | NCT00003789 | Recurrent Melan... Stage III Melan... | isolated limb p... melphalan recombinant tum... pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma | NCT00002492 | Sarcoma | cisplatin doxorubicin hyd... isolated limb p... conventional su... brachytherapy radiation thera... | 18 Years - 120 Years | University of Miami | |
| A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma | NCT00001296 | Melanoma | melphalan tumor necrosis ... interferon-gamm... hyperthermic is... | - | National Institutes of Health Clinical Center (CC) | |
| A Randomized Controlled Study Comparing Priming Solution Containing Crystalloid or Packed Red Blood Cells in Patients Treated With Isolated Limb Perfusion. | NCT03073304 | Melanoma Sarcoma | Crystalloid bas... Erythrocyte bas... | 18 Years - | Vastra Gotaland Region | |
| A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma | NCT00001296 | Melanoma | melphalan tumor necrosis ... interferon-gamm... hyperthermic is... | - | National Institutes of Health Clinical Center (CC) | |
| Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma | NCT02507076 | Basal Cell Carc... Eccrine Carcino... Recurrent Adult... Recurrent Melan... Recurrent Skin ... Squamous Cell C... Stage III Adult... Stage IIIB Mela... Stage IIIC Mela... Stage IV Adult ... Stage IV Melano... | isolated limb p... melphalan quality-of-life... | 18 Years - | Albert Einstein College of Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
